< 1 minute read
Sep. 18, 2021

BAY 1895344: A Selective Oral ATR Kinase Inhibitor

BAY 1895344

selective oral ATR kinase inhibitor in Ph. I for adv. solid tumors and lymphomas from HTS and modeling on PI3Kg structure J. Med. Chem., Jun. 5, 2020 Bayer AG, Berlin, DE

Drug Hunter Team


Other molecules you may be interested in